Finance

Lists
Why is BIOV up 3,91%?
Dive Deeper
BIOV:SWX
BioVersys AG
23,90 CHF
+3,91%
(+0,90) 1D
18-ноя., 17:36:29 GMT+1  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for BIOV...
Open
23,00 CHF
High
23,90 CHF
Low
22,50 CHF
Mkt. cap
140,18 млн
Avg. vol.
2,36 миң
Volume
14,33 миң
52-wk high
30,70 CHF
52-wk low
21,20 CHF
EPS
-3,73 CHF
Shares outstanding
5,87 млн
No. of employees
38
Open
23,00 CHF
High
23,90 CHF
Low
22,50 CHF
Mkt. cap
140,18 млн
Avg. vol.
2,36 миң
Volume
14,33 миң
52-wk high
30,70 CHF
52-wk low
21,20 CHF
EPS
-3,73 CHF
Shares outstanding
5,87 млн
No. of employees
38
News stories
From web sources and news partners
About BioVersys AG
CEO-
Employees38
Founded2008
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,30 млн
1,30 млн
1,01 млн
1,01 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,14 млн
5,14 млн
6,78 млн
6,78 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,51 млн
1,51 млн
1,51 млн
1,51 млн
Operating expense
6,60 млн
6,60 млн
8,29 млн
8,29 млн
Total operating expenses
6,60 млн
6,60 млн
8,29 млн
8,29 млн
Operating income
-5,30 млн
-5,30 млн
-7,28 млн
-7,28 млн
Other non operating income
126,50 миң
126,50 миң
-306,50 миң
-306,50 миң
EBT including unusual items
-5,40 млн
-5,40 млн
-7,79 млн
-7,79 млн
EBT excluding unusual items
-5,40 млн
-5,40 млн
-7,79 млн
-7,79 млн
Income tax expense
8,00 миң
8,00 миң
7,00 миң
7,00 миң
Effective tax rate
-0,15%
-0,15%
-0,09%
-0,09%
Other operating expenses
-46,50 миң
-46,50 миң
-
-
Net income
-5,41 млн
-5,41 млн
-7,80 млн
-7,80 млн
Net profit margin
-415,04%
-415,04%
-773,31%
-773,31%
Earnings per share
-
-
-
-
Interest and investment income
1,50 миң
1,50 миң
17,00 миң
17,00 миң
Interest expense
-266,00 миң
-266,00 миң
-341,50 миң
-341,50 миң
Net interest expenses
-264,50 миң
-264,50 миң
-324,50 миң
-324,50 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,26 млн
-5,28 млн
-7,18 млн
-7,18 млн
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору